Posted by AGORACOM-JC
at 5:37 PM on Monday, November 18th, 2019
SPONSOR: NORTHBUD (NBUD:CSE)
Sustainable low cost, high quality cannabinoid production and
procurement focusing on both bio-pharmaceutical development and
Cannabinoid Infused Products. Learn More.
THC-infused edibles and CBD-infused edibles
When cannabis is ingested, the THC is metabolized by the liver
With edibles coming to brick-and-mortar shops in mid-December, users are looking to get high without the smoke.
But when choosing edibles, users will want to pay attention to
whether the product has CBD or THC, two compounds with very different
effects.
CBD
CBD, the non-psychoactive component within cannabis has been widely
touted for its medical benefits to help people with, among other
conditions, chronic pain. The World Health Organization (WHO) reports
CBD is not physically addictive.
By comparing those administered doses of active CBD to those given as
a placebo, researchers said that “while the number of studies is
limited, the evidence from well-controlled human experimental research
indicates that CBD is not associated with abuse potential.â€
CBD leads to slower effects that aren’t psychoactive in
nature — meaning they aren’t the effects you see portrayed in pop
culture.
The effects from CBD will be tame and mellow compared to its
psychoactive opposite, THC. Most medical cannabis includes CBD rather
than THC, with CBD already available in capsule form in legal stores.
THC
When most people think of cannabis’ effects, they think of THC. Many
of the new cannabis products slated to enter stores in mid-December will
focus on THC.
When cannabis is ingested, the THC is metabolized by the liver,
transforming itself into 11-hydroxy-THC. This metabolite is up to four
times faster in crossing the blood-brain barrier than average THC, and
is why edibles are associated with intense, vivid and longer-lasting
experiences.
THC normally gets pointed at as the compound that creates the potential for withdrawal symptoms among some heavy users.
An evidence brief compiled by the Canadian Public Health Association (CPHA) states that “cannabis is addictive, though not everyone who uses it will develop an addiction.â€
While using cannabis oil or edibles with THC, users may get addicted
or experience habit-formation. Products that only include CBD don’t
appear to become addictive.
Posted by AGORACOM-JC
at 12:49 PM on Monday, November 18th, 2019
Senior Management including; Andrew Ryu, Jeffrey Stevens and Steve Kang have voluntarily agreed to reduce their compensation by approximately 40% effective immediately
Additionally, the Company’s 10% rolling stock option plan was re-approved and confirmed
Shareholders passed a special resolution to change the name of the Company from Datametrex AI Limited to Nexalogy AI Limited as well as a share consolidation plan of up to 8 to 1Â
TORONTO, Nov. 18, 2019 – Datametrex AI Limited (the “Company†or “Datametrexâ€) (TSXV: DM, FSE: D4G) is pleased to announce that the Senior Management including; Andrew Ryu, Jeffrey Stevens and Steve Kang have voluntarily agreed to reduce their compensation by approximately 40% effective immediately. The Company also completed the integration of back office functions of Nexalogy. As a result, the Company has cut down the number of staff and office space as a part of its cost saving strategy.
“Our goal is to grow the business and share price organically rather
than doing a share consolidation. The entire team is aligned with our
shareholders in getting the Company back on track,†says Marshall
Gunter, CEO of the Company.
The Company is also pleased to announce completion of it’s annual and
special meeting. At the meeting, Andrew Ryu, Charles Schade, Janeen
Stodulski, David Ellison and John McMullen were elected as directors of
the Company and KPMG were appointed as auditors for the Company.
Additionally, the Company’s 10% rolling stock option plan was
re-approved and confirmed and shareholders passed a special resolution
to change the name of the Company from Datametrex AI Limited to Nexalogy
AI Limited as well as a share consolidation plan of up to 8 to 1.
The Company’s name will not be changed until the Company files
articles of amendment and obtains the necessary regulatory approvals.
While the resolution gives discretion to the Company’s board and
management to effect the share consolidation, no decision has been made
by the Company to complete the consolidation or what the consolidation
ratio will be. If and when the Company decides to implement the share
consolidation, a further press release will be disseminated with the
details of the share consolidation.
About Datametrex
Datametrex AI Limited is a technology focused company with exposure
to Artificial Intelligence and Machine Learning through its wholly owned
subsidiary, Nexalogy (www.nexalogy.com).
For further information, please contact:
Jeff Stevens – President Phone: 647-777-7974 Email: [email protected]
Forward-Looking Statements
This news release contains “forward-looking information†within
the meaning of applicable securities laws. All statements contained
herein that are not clearly historical in nature may constitute
forward-looking information. In some cases, forward-looking information
can be identified by words or phrases such as “mayâ€, “willâ€, “expectâ€,
“likelyâ€, “shouldâ€, “wouldâ€, “planâ€, “anticipateâ€, “intendâ€,
“potentialâ€, “proposedâ€, “estimateâ€, “believe†or the negative of these
terms, or other similar words, expressions and grammatical variations
thereof, or statements that certain events or conditions “may†or “willâ€
happen, or by discussions of strategy.
Readers are cautioned to consider these and other factors,
uncertainties and potential events carefully and not to put undue
reliance on forward-looking information. The forward-looking information
contained herein is made as of the date of this press release and is
based on the beliefs, estimates, expectations and opinions of management
on the date such forward-looking information is made. The Company
undertakes no obligation to update or revise any forward-looking
information, whether as a result of new information, estimates or
opinions, future events or results or otherwise or to explain any
material difference between subsequent actual events and such
forward-looking information, except as required by applicable law.
Posted by AGORACOM-JC
at 11:38 AM on Monday, November 18th, 2019
SPONSOR: CardioComm Solutions (EKG: TSX-V)
– The heartbeat of cardiovascular medicine and telemedicine. Patented
systems enable medical professionals, patients, and other healthcare
professionals, clinics, hospitals and call centres to access and manage
patient information in a secure and reliable environment.
Congress Eyes Privacy Protections for Data on mHealth Wearables
A bill introduced this week – and another introduced this past June –
aim to protect patient health data gathered on consumer-facing mHealth
wearables like smartwatches, fitness bands and even apps.
US Senators Bill Cassidy (R-LA) and Jacky Rosen (D-NV) have introduced a bill this week that aims to define how data gathered on smartwatches, fitness bands and other connected health devices – including mHealth apps – dis protected and prevent “entities that collect consumer health information†from exposing that data to other parties.
November 15, 2019 – Congress is jumping into the long-simmering
debate over the protection of health data on consumer-facing mHealth
wearables.
US Senators Bill Cassidy (R-LA) and Jacky Rosen (D-NV) have introduced a bill this week
that aims to define how data gathered on smartwatches, fitness bands
and other connected health devices – including mHealth apps – dis
protected and prevent “entities that collect consumer health
information†from exposing that data to other parties.
“The introduction of technology to our health care system in the form
of apps and wearable health devices has brought up a number of
important questions regarding data collection and privacy,†Rosen said in a press release
announcing the bill, to be called The Stop Marketing And Revealing The
Wearables And Trackers Consumer Health (SMARTWATCH) Data Act. “This
commonsense, bipartisan legislation will extend existing health care
privacy protections to personal health data collected by apps and
wearables, preventing this data from being sold or used commercially
without the consumer’s consent.â€
The bill’s introduction comes amidst a flurry of news in the
consumer-facing mHealth arena, including Google’s pending purchase of
Fitbit and the announcement that the tech giant will be working with Ascension
– the largest non-profit health system in the US – to integrate mHealth
technology and data collection into the health system’s care programs.
“The Google/Ascension news has brought needed scrutiny to the
security of Americans’ health data,†Cassidy said in the press release.
“The SMARTWATCH Act prevents big tech data harvesters from collecting
intimate private data without patients’ consent. Americans should always
know their health information is secure.”
The bill defines consumer health information as “any information
about the health status, personal biometric information, or personal
kinesthetic information (such as keystroke or gait patterns and sleep
information) about a specific individual that is created or collected by
a personal consumer device, whether detected from sensors or input
manually.†This would include not only physiological, biological and
behavioral data, but “deoxyribonucleic acid, imagery of the iris,
retina, fingerprint, face, hand, palm, vein patterns, and voice
recordings, from which an identifier template, such as a faceprint, a
minutiae template, or a voiceprint, can be extracted.â€
Under the bill, the organization that collects that data would be
barred from transferring, selling, sharing or allowing access to that
data, unless aggregated and anonymized, to “any domestic information
broker or other domestic entity†whose primary function is to analyze
that information for profit or whose primary purpose is to add
commercial value to the entity collecting the data.
The legislation mirrors a bill introduced in June by Senators Amy
Klobuchar (D-MN) and Lisa Murkowski (R-AK) that aims to protect consumer
health information not protected under current laws.
The Protecting Personal Health Data Act (S.1842)
would require the development of regulations that strengthen privacy
and security protections, including setting consent standards that
address genetic, biometric and general personal health data, and give
consumers the ability to access, amend and delete their data. It would
also create a National Task Force on Health Data Protection that would:
evaluate and provide input to address cybersecurity risks and
privacy concerns associated with consumer products that handle personal
health data, and the development of security standards for consumer
devices, services, applications, and software; and
study the long-term effectiveness of de-identification methodologies
for genetic and biometric data, and advise on the creation of resources
to educate consumers about direct-to-consumer genetic testing.
Tags: EKG, mhealth, small cap stocks, stocks, tsx, tsx-v Posted in CardioComm Solutions | Comments Off on CardioComm Solutions $EKG.ca – Congress Eyes Privacy Protections for Data on #Mhealth #Wearables $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca
Posted by AGORACOM-JC
at 10:14 AM on Monday, November 18th, 2019
Investment Highlights
Kenbridge property has a measured and indicated resource of 7.14 million tonnes at 0.62% nickel, 0.33% copper
17.5 (21.8 fully diluted) percent equity stake in Eloro Resources and 2 percent NSR in their La Victoria property
Kenbridge Ni Project (ON, Canada)
Advanced stage deposit remains open in three directions, is
equipped with a 623m deep shaft and has never been mined.
Preliminary Economic Assessment completed and updated returned robust project economics and operating costs including a NPV of C$253M and cash costs of US$3.47/lb of nickel net of copper credits.
Plans for Kenbridge include updating PEA,
advancing the project through to feasibility and exploring the open
mineralization at depth
FULL DISCLOSURE: Tartisan Nickel Corp. is an advertising client of AGORA Internet Relations Corp.
Posted by AGORACOM-JC
at 5:05 PM on Friday, November 15th, 2019
SPONSOR: PRIMO NUTRACEUTICALS INC.
(CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV)
provides strategic capital to the thriving cannabis cultivation
sector through ownership and development of commercial real estate
properties. The company also offers fully built out turnkey facilities
equipped with state-of-the-art growing infrastructure to cannabis
growers and processors. Click here for more info.
Feds Finally Crafting National CBD Rules
After years of states passing their own rules concerning cannabidiol – more commonly known as CBD – the federal government is now quietly taking the first steps to regulate it.
Photo: Sven Hoppe/dpa (Photo by Sven Hoppe/picture alliance via Getty Images)
dpa/picture alliance via Getty Images
The F&B industry is ahead of them: You can already get CBD in
gummies, oils, lotions and juices, and Arizona Iced Tea and Ben and
Jerry’s have been testing it. But as states moved to regulate, the
federal government sat on the sidelines, leaving CBD in legal limbo.
That began to change a couple of weeks ago in what could be the
beginning of the biggest change for the CBD market since the Farm Bill
of 2018 ended classifying hemp and products derived from it as
controlled substances.
The United States Department of Agriculture (USDA) in late October
published its interim final rules for domestic hemp production in the
Federal Register, including rules regarding CBD, a product of hemp. How
big a deal could this be? Think about the end of Prohibition. The
federal government is finally creating standards that could help create a
national marketplace. That could help move CBD from the margins to the
mainstream, adding security, safety and consistency to manufacturing.
The proposed rules come as sales of CBD are expected to reach $13
billion this year, even as federal law tries to catch up with demand.
CBD is getting too big to be ignored, and lack of reliable information
and uniform regulation adds to confusion. The feds are finally arriving
on the scene (let’s not call it a party) with the structure that’s
needed.
The new rules would include federal aid for hemp farmers and could
help ease access to insurance and loans, leading to bigger supply and
more financing. There are also tough provisions, which could be good for
consumers and companies, but will add costs for manufacturers and
others in the supply chain. Hemp samples, for instance, would have to be
delivered to DEA-certified labs 15 days before harvest and certified.
The USDA, however, is only the first federal agency to lay its hands
on hemp and CBD. The Food & Drug Administration (FDA), which
approved seizure drug Epidolex containing CBD, classifies it as an
active ingredient in medications – which it regulates. The agency in
late October said it’s continuing “to explore potential pathways for
various types of CBD products to be lawfully marketed.†Manufacturing
isn’t currently subject to FDA review. The USDA’s actions could help
change that. The Grocery Manufacturers Association, for instance, is
pushing for the FDA to issue final CBD rules instead of allowing “a maze
of inconsistent, and often contradictory, state and local regulationsâ€
that can lead to a “regulatory mess.â€
The USDA has also begun to regulate THC, the psychoactive ingredient
in hemp sometimes included with CBD. The USDA indicates that,
potentially, hemp could contain up to 0.3 percent THC or
tetrahydrocannabinol, the limit in Canada and many other countries. The
FDA is likely to fall in line with that as CBD becomes more common.
CBD’s popularity comes with often-exaggerated claims; some people
look at it as a cure-all. That also could change with regulation. The
FDA already issued warnings to companies making medical claims. As the
feds begin to regulate CBD, some misinformation may vanish from
marketing, which could lower sales, as the market sorts itself out,
“weeding out†certain companies as others grow.
Money is already flowing into companies working with CBD. Altria,
parent of cigarette giant Philip Morris, poured $1.8 billion into
cannabis company Cronos Group. Beer distributors and Arizona Iced Tea
are infusing drinks with CBD, hoping to experience (puns are just too
easy here) higher sales. As the market for CBD continues to expand, it’s
only a matter of time before CBD gets what the Grocery Manufacturers
Association wished for: federal regulation.
While most industries dread regulation, it could prove essential for
CBD to truly take off in food and beverage, providing safety to
consumers and security for producers. The USDA has stepped off the
sidelines, and the FDA is talking about stepping in. It looks like
federal rules may finally be arriving, bringing standards and — get
ready — red tape (which means compliance costs) in a trade-off for
quality control, consumer protection, and growth prospects. It’s
starting to look like a national marketplace for CBD may no longer be a
pipe dream.
Posted by AGORACOM-JC
at 3:30 PM on Friday, November 15th, 2019
SPONSOR: New Age Metals Inc.
The company’s Lithium Division has already made significant
acquisitions in Canada and the USA. The company also owns one of North
America’s largest primary platinum group metals deposit in Sudbury,
Canada. Updated NI 43-101 Mineral Resource Estimate 2,867,000 PdEq
Measured and Indicated Ounces, with an additional 1,059,000 PdEq Ounces
in the Inferred. Learn More.
Europe EVs now use 57% more lithium carbonate equivalent
Changing mix of EV sales is most noticeable in Europe where the average battery in new passenger EVs sold in September contained 15.8kg of LCE
Constitutes a 57% surge compared to last year, thanks in no small part to the popularity of the Tesla Model 3 on the continent
Electric car pioneer Tesla is already producing units on a trial basis at its giant Shanghai gigafactory despite only breaking ground this year, but thanks to changes to the Chinese EV subsidy program, demand for locally-made Teslas may fall short of expectations.
On Monday, China’s automobile manufacturing industry body said fewer
new energy vehicles, or NEVs as they are termed domestically, could be
sold this year than in 2018 (last year sales boomed by more than 60%).
Sales of NEVs – which apart from battery-powered vehicles also
include hybrids and fuel cell cars – fell by more than 45% in October
from the same month last year, adding to the woes of an industry coping
with 16 straight months of declining overall sales.
Changes to China’s EV incentive program favour hybrids so lithium loads may start to tend downwards in that country too
Adamas Intelligence tracks the battery capacity (and the metals used in them)
of electric vehicles sold around the world and the slowdown in the EV
market, where lithium-ion batteries dominate, has already showed up in
raw material deployment data.
In September 2019, the average new passenger EV including plug-in and
conventional hybrids sold globally contained 12.2 kilograms of lithium
carbonate equivalent (LCE), a modest increase of 4% over 2018, according
to the latest Adamas report.
The Toronto-based research company’s data shows China still
outstripped global growth in September with a 7% increase in LCE on a
per-EV basis, reaching a sales-weighted average of just shy of 20kg
thanks to the prevalence of full electric models in the country.
That’s in stark contrast to Japan, where hybrids represent more than
90% of EV sales and average batteries contain only 1.1kg of LCE. Changes
to China’s EV incentive program favour hybrids so lithium loads may
start to tend downwards in that country too.
The changing mix of EV sales is most noticeable in Europe where the
average battery in new passenger EVs sold in September contained 15.8kg
of LCE.
That constitutes a 57% surge compared to last year, thanks in no
small part to the popularity of the Tesla Model 3 on the continent.
Teslas have always had bigger batteries than competitor cars to help
with fast-charging and range.
In the US the trend is in the opposite direction – with passenger EVs
leaving showrooms containing on average 15.2kg of LCE, 12% less than in
September 2018.
Secured New Health Canada Device Clearance and Exclusive Canadian Sales Rights for US Medical ECG Device Manufacturer Read More
Entered into an exclusive sales and marketing agreement for the GEMS™ Sirona with California-based Datrix LLC
Under the multi-year, renewable agreement, CardioComm assumes the
role of exclusive Canadian distributor of the Datrix ECG recorders under
the GEMS™ Sirona brand device.
Secured Newest US and Canadian Medical Device 13485:2016 MDSAP Certification Read More
Completed its ISO 13485:2016 certification in compliance with the
Medical Device Single Audit Program, a mandatory requiment under Health
Canada and accepted as an equivalent quality management certification by
the USA Food and Drug Administration.
Announced ECG Services Integration and Co-Marketing Agreement with California-Based BodiMetrics LLC Read More
GEMS™ Universal will be available under two subscription models:
$6 US per month with one free ECG interpretation included; and,
$69 US per year with 12 free ECG interpretations that may be requested any time during the one year subscription.
Company Accolades
FULL DISCLOSURE: CardioComm Solutions Inc. is an advertising client of AGORA Internet Relations Corp.
Posted by AGORACOM-JC
at 10:57 AM on Friday, November 15th, 2019
SPONSOR: BetterU Education Corp.
aims to provide access to quality education from around the world.
The company plans to bridge the prevailing gap in the education and job
industry and enhance the lives of its prospective learners by developing
an integrated ecosystem. Click here for more information.
Edtech Startups Transforming The Way Indian Children Learn
Many edtech startups today are leveraging the increasing literacy rate coupled with increased internet penetration
These startups are trying to address the most important issue faced by the Indian education system
India has roughly 1.5 million schools, 38,000 colleges, and 760 universities as per MHRD. This translates into one school per 200 school-goers and one college per 3,700 college-goers. According to a report by management consulting firm Technopak in 2016, India’s education market is valued at $100 Bn while the digital learning market is estimated at $2 Bn. The report also said that the digital learning market is expected to reach $5.7 Bn by 2020 as the number of internet users is increasing.
Many edtech startups today are leveraging the increasing literacy
rate coupled with increased internet penetration. These startups are
trying to address the most important issue faced by the Indian education
system, which is the lack of upgrade. By bringing in technology, these
startups are trying to bridge the gap between rural and urban India as
well.
Samsung-backed TagHive recently launched an AI-powered classroom
engagement solution, Class Saathi, to make tech-based learning
accessible and affordable for schools in rural India with little or no
infrastructural investments. The Central Board of Secondary Education
(CBSE) also partnered with Microsoft India and IBM to focus on tech
reskilling for teachers and AI curriculum in schools. Through this, CBSE
will be conducting capacity building programmes for high school
teachers with an aim to integrate cloud-powered technology in K12
teaching and inculcating digital teaching skills in educators through
the curriculum as well as extra-curricular training.
Posted by AGORACOM-JC
at 10:47 AM on Friday, November 15th, 2019
SPONSOR:ThreeD Capital Inc. (IDK:CSE)
Led by legendary financier, Sheldon Inwentash, ThreeD is a
Canadian-based venture capital firm that only invests in best of breed
small-cap companies which are both defensible and mass scalable. More
than just lip service, Inwentash has financed many of Canada’s biggest
small-cap exits. Click Here For More Information.
‘Unknown Fund’ to Donate $75M in Bitcoin to Crypto, Anonymity-Focused Startups
An anonymous organization dubbed “Unknown Fund†is planning to give away $75 million in Bitcoin (BTC) to startups that are focused on anonymity and the protection of personal data.
An anonymous organization dubbed “Unknown Fund†is planning to give away $75 million in Bitcoin (BTC) to startups that are focused on anonymity and the protection of personal data.
In a press release
on Nov. 13, the organization — which consists of “ordinary, anonymous
people from different countries†— said it will donate the money to
startups which support the idea of anonymity and specifically operate in
such fields as the protection of personal information, tools of anonymity, cryptocurrencies and blockchain.
Fighting the misuse of people’s personal data
The idea behind the donations is to fight the manipulation of people
by politics, social media networks and other parties who collect
individuals’ personal data, which Unkown Fund says has proved to be an
“amazing and frightening†tool.
The project supposedly started on 4chan, an anonymous
English-language imageboard, and claims to have the support of
hacktivist group Anonymous, which it cites as saying:
“Now the main goal of large corporations is to collect as much
information as possible about the personal lives of people, and then use
it for their enrichment. And they do a great job of it by making
ordinary people get poorer. We are ready to fight for change and protect
people.”
The Unknown Fund argues that the deployment of blockchain technology
and digital currencies could help protect people’s rights and freedoms,
and eventually develop a new environment with a trustworthy monetary
system.
Blockchain in personal data protection
Many industry players have questioned blockchain’s ability to ensure
personal data protection. Speaking with Cointelegraph in August, Timothy
Paolini, a board member at NYU Blockchain, stated:
“Blockchains are built around the principles of decentralization,
removing the single point of failure risk (think Equifax servers) and
cutting out unnecessary third parties by establishing a more direct,
peer-to-peer network. This also maintains your privacy and control of
your data from third-party apps as data rests at the protocol instead of
the application layer.â€
Deirdre K. Mulligan, an assistant professor at the University of
California, Berkeley School of Information, argued that blockchains do
not inherently protect your identity, as they can be manipulated by
their architects to be centralized and non-anonymous. Mulligan stated:
“Companies can exert a lot of control over how they design an application, through its architecture, default settings, what it communicates in its privacy policies, and what it does in practice. The value for a consumer concerned about her privacy would depend on the blockchain application and the kind of data collected and processed by it.â€
Posted by AGORACOM-JC
at 4:33 PM on Thursday, November 14th, 2019
SPONSOR: CardioComm Solutions (EKG: TSX-V)
– The heartbeat of cardiovascular medicine and telemedicine. Patented
systems enable medical professionals, patients, and other healthcare
professionals, clinics, hospitals and call centres to access and manage
patient information in a secure and reliable environment.
mHealth Solutions Market Forecasting CAGR of 34.34%
mHealth solutions market is expected to rise from its initial estimated value of USD 28.06 billion in 2018 to a projected value of USD 297.70 billion by 2026, registering a CAGR of 34.34% in the forecast period of 2019-2026
This rise in market value can be attributed to lower physician ratio as compared to patients requiring healthcare provisions.
Market Definition: Global mHealth Solutions Market
mHealth solutions can be defined as the technology utilized in
providing healthcare services and products through smart devices and
smart phones. This technology is used for collecting patient data, their
patient history and also through this technology, healthcare providers
can ease their workflow helping them work in a systematic and effective
way.
Key Market Competitors: Global mHealth Solutions Market
Medtronic; Cerner Corporation; Koninklijke Philips N.V.; ZTE
Corporation; Nokia; AirStrip Technologies; BioTelemetry, Inc.; Apple
Inc.; iHealth Labs Inc.; athenahealth, Inc.; AliveCor, Inc.; Zebra
Technologies Corp; Johnson & Johnson Services, Inc.; Cisco; AT&T
Intellectual Property; AgaMatrix; OMRON Corporation; Withings and
Qualcomm Technologies, Inc. are few of the major competitors currently
working in the mHealth solutions market.
Market Drivers:
Growth in adoption and usage of smart devices and smart phones in
healthcare and medical monitoring; this factor is expected to act as a
driver for the market growth
Increasing focus on patient-focused and individual specific
healthcare provisions; this factor is expected to drive the market
growth
Market Restraints:
Absence of any regulations and standardization in the market restraining the market growth
Lack of enthusiasm in providing information regarding the
identification of correct mHealth applications and solutions; this
factor is expected to restrain the market growth
Key Developments in the Market:
In January 2019, Zebra Technologies Corp announced that they are
planning to launch “DS1800-HC†collection of scanners and “TC51-HCâ€
cellular PC for healthcare professionals in India. These products will
assist physicians in easing their workflow resulting in increased
productivity and effectiveness.
In March 2016, ZTE Corporation announced the launch of all-in-one
mHealth product that utilizes a number of smart devices and incorporates
IoT technology in identifying the diseases & disorders and
providing patient specific medical care.
Global mHealth solutions market is highly fragmented and the major
players have used various strategies such as new product launches,
expansions, agreements, joint ventures, partnerships, acquisitions, and
others to increase their footprints in this market. The report includes
market shares of mHealth solutions market for global, Europe, North
America, Asia-Pacific, South America and Middle East & Africa.
